Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Quester VCT PLC (KAY)

  Print      Mail a friend       Annual reports

Thursday 06 May, 2004

Quester VCT PLC

Final Results

QUESTER VCT PLC ('the Company')

Summary of results for the year ended 31 January 2004

Per Ordinary Share        2004        2003        2002
Capital Values                                        
Net asset value           50.1        58.4        78.3
Share price               45.0        54.0        87.5
Return and Dividends                                  
Dividend                     -           -           -
Cumulative dividend       41.5        41.5        41.5
Total Return*             91.6        99.9       119.8
*Net asset value                                      
plus cumulative                                       

Shareholder information

Annual General Meeting 11.00 a.m. on 8 June 2004



After the difficult conditions encountered in the two previous years, it is
encouraging to be able to report a level of progress in the Company's
investment portfolio against a background of greater stability in business
conditions generally, more favourable conditions for the availability of
private equity finance and an improved stock market.

While the accounts for the year show a reduction in the net asset value per
share of the Company, the Board considers that, generally, the performance of
companies in the portfolio during the year ended 31 January 2004 has been
somewhat more encouraging.

Venture capital portfolio performance

The performance of the venture capital portfolio generally has reflected more
stable business conditions, the more favourable conditions for the availability
of private equity finance and the improved stock market conditions.

Among the unquoted investments held at 31 January 2004, a number of the
companies remain relatively early stage businesses, operating in a number of
distinct technology areas. After suffering from the harsh economic environment
prevailing over the previous two years or so, in the year ended 31 January 2004
such companies have in general started to make better progress.

It is pleasing to be able to report the sale of the investment in CDC Solutions
Limited ('CDC'), a software company, to Information Holdings Inc., a US-based
information services group listed on the New York Stock Exchange. This
transaction has been accounted for in the year ended 31 January 2004 on a no
profit/no loss basis, but in addition to securing, at completion, a return to
the Company in cash and cash equivalents of substantially all of the original
cost of the investment, the transaction offers the prospect of a multiple of
cost ultimately being achieved depending on the future performance of the
combined business within the enlarged group.

Despite a generally more favourable business background, we have to report the
failure of one of the Company's investments, resulting in the write-off of some
£1.5 million. This disappointing result, and downward adjustments in the
carrying value of certain other unquoted venture capital investments, have
contributed to a decline in the reported net asset value per share of the

It has been encouraging that one of the key companies in the portfolio, Anadigm
Limited ('Anadigm'), has been successful in raising a new funding round, from a
syndicate that has attracted a leading venture capital firm as a new investor,
as well as including further participation from the Company and other Quester
funds. Current conditions in the market for private equity finance, however,
and the stage of development reached by the company meant that the new round
was priced at a lower level than previously. Although, as a result, this was
one of the investments

where a downward valuation adjustment was required, the Board is satisfied that
there are strong prospects for Quester VCT achieving an ultimate realisation of
its investment in Anadigm at a multiple of its total original cost.

The Board considers that, after careful consideration, the valuations adopted
at 31 January 2004 give a fair reflection of the overall value of the unquoted
portfolio in accordance with the Guidelines issued by the BritishVenture
Capital Association ('BVCA').

A more detailed review of the performance of the venture capital portfolio is
provided in the investment manager's report.

Income statement and dividends

The profit and loss account for the year ended 31 January 2004 shows a loss
before tax of £1.4 million (4.0 pence per share), with no tax being payable.
The loss comprises net gains from the realisation of investments of £0.3
million, a write-off of investments of £1.5 million and a deficiency of net
income against expenses of £0.2 million.

The Statement of Total Recognised Gains and Losses shows net unrealised losses
of £1.5 million (4.5 pence per share). This includes downward adjustments in
the carrying value of unquoted venture capital investments totaling £2.2
million, net of unrealised gains on the quoted venture capital investments and
FTSE 350 equities of £0.7 million.

The total return attributable to shareholders for the year amounted to a net
loss of £2.9 million or 8.5 pence per share. In these circumstances, the
directors do not recommend the payment of a dividend.

A transfer of £2.2 million has been made from the special reserve created on 3
November 2000, following the reduction of the share premium account,
representing the total of realised losses on investments incurred during the
year. Subject to the approval of resolution 7 in the Notice of Annual General
Meeting, this transfer will enable dividends to be paid out of capital gains
achieved from future investment realisations at an earlier date than would
otherwise be possible. Following this transfer, the profit and loss account
shows a net credit balance at 31 January 2004 of £3.1 million.

Balance sheet

At 31 January 2004 the total of venture capital investments, at valuations in
accordance with the BVCA Guidelines, amounted to £9.0 million including £
932,000 in quoted venture capital investments (5.5% of net assets) and £8.1
million in unquoted investments (47.2% of net assets).

Many of the companies in which Quester VCT has invested will require further
rounds of finance as they seek to develop to a point when they become cash
generative. It is important that, wherever appropriate, Quester VCT should be
in a position to contribute to this funding process. For this purpose the
Company has identified and earmarked funds for follow-on investment in our
existing portfolio companies. These funds are represented in terms of our
assets by the portfolio of

FTSE 350 equities and fixed-interest securities, and are considered to be at a
satisfactory level in relation to the likely requirements: at 31 January 2004
their overall value amounted to £5.1 million comprising £3.0 million in
fixed-interest securities (17.7% of net assets) and £2.0 million in equities
(12.0% of net assets).


We remain positive about the outlook for the Company and its investments. The
current portfolio includes a number of investments that we believe have
significant potential for the future.

It is the intention of the Board to continue, wherever possible, with the
policy of maximum dividend distribution arising from realised profits, balanced
against the need to retain cash to meet ongoing financial commitments and to
make new investments. At the present time, however, it is not possible to
predict either the timing or level of the realisation of capital profits, and
accordingly the amount and timing of future dividends remains uncertain.

Tom Scruby


6 May 2004



After the difficult conditions in the venture capital market in the two
previous years, it has been encouraging in the year ended 31 January 2004 to
see greater stability in the venture capital portfolio as a whole and improved
stock market conditions.

Another positive development has been the re-emergence of M&A activity in the
unquoted company sector. As a result of a transaction entered into towards the
year end, the Company is well placed to gain future benefits from the
realisation of its investment in CDC Solutions Limited, although at 31 January
2004 this transaction has been accounted for on a no profit/no loss basis.

The accounts for the year ended 31 January 2004 show a decline in the reported
net asset value per share of the Company. However, in the light of improved
business conditions for many of our portfolio companies, the success of new
funding rounds and, in relation to a number of the portfolio companies, the
prospects for M&A activity, we are optimistic as to the prospects for the
venture capital portfolio as a whole.

Progress with venture capital investment

During the year we have supported a number of companies in the investment
portfolio with further rounds of finance, a total of £879,000 being provided as
follow-on finance to eight of the unquoted portfolio companies. Members of the
Quester team have continued to be actively involved with the companies in the
portfolio and in many cases have made significant contributions to their key
strategic business planning decisions.

The portfolio suffered one business failure during the year, the investment of
£1,526,000 in Bowman Power Limited being written off as at 31 January 2004.The
disappointing result follows a company performance, during 2003, which was a
long way below the investment plan. This led the company to be unable to raise
further finance from its broadly-based syndicate of investors: a small recovery
is anticipated from the administration process.

In the case of the new financing round of Anadigm Limited ('Anadigm'), in which
the Company and other Quester funds participated, current conditions in the
private equity market and the stage of development reached by the investee
company resulted in the new round being priced at a lower level than
previously.A downward adjustment of £1,111,000 has been made to the previous
carrying value of this investment.

Anadigm provides breakthrough technology to the electronics market, its devices
enabling electronic system developers to gain significant improvements in
design times, control and flexibility in the production of analog circuits. The
market for the company's products is expected to be in excess of $500 million,
and Anadigm has the potential to dominate this market with technology which is
heavily protected by intellectual property patents. Despite the valuation
adjustment necessitated at

31 January 2004, we believe that Anadigm offers Quester VCT strong prospects of
achieving an ultimate realisation at a multiple of the total original cost of
this investment.

Provisions have been made in respect of a number of other investments where the
business has fallen behind plan or to reduce valuations in order to reflect
current conditions in the private equity market.The total of provisions made
during the year against cost of the unquoted venture capital investments,
inclusive of the adjustment in respect of Anadigm, amounted to £2,215,000
(representing unrealised losses), while a provision of £181,000 taken in the
previous year as a permanent diminution in value has now been written back.

The remaining portfolio of quoted venture capital investments - including a
modest remaining holding in SurfControl plc and holdings in XKO Group plc and
Crown Sports plc - produced an unrealised appreciation over the year of £

Realisation of venture capital investments

Towards the year end, the Company's investment in CDC Solutions Limited, a
software company specialising in regulatory publishing solutions for the life
sciences industry, was sold to a subsidiary of the US-based information
services group Information Holdings Inc. ('IHI'). The terms of the acquisition
have resulted in the Company receiving, at completion, substantially all of its
£1,020,000 cost of investment back in cash and cash equivalents. Depending on
future performance, a multiple of cost, and a substantial uplift on the
previous carrying value of £1,770,000, may ultimately

be achieved.

At 31 January 2004, this transaction has been accounted for on a no profit/no
loss basis. Additional proceeds receivable, if any, will be recognised in
future accounting periods once the amounts become certain.

The opportunity was taken during the year to sell the remaining holding in ADVA
A.G. Optical Networking and part of the remaining holding in SurfControl plc,
these transactions together realising proceeds of £298,000 and a profit of £
149,000 as against the carrying value at the previous year end.

Venture capital investments made during the year

Follow-on investments were made during the year as shown below (amounts shown
net of repayments of earlier bridging finance):

Company                                 Industry Sector                 £'000
Advanced Valve Technologies Limited     Industrial products &             362
Anadigm Limited                         Semiconductors                    245
The Casella Group Limited               Industrial products &              90
Communication & Control Electronics     Electronics                        75
Elateral Holdings Limited               Software                           61
Other (3)                                                                  46

Sector analysis of the venture capital portfolio

The portfolio of Quester VCT is balanced by sector and well spread. A summary
of the sectors covered by the portfolio is as follows:

Industry Sector                   Existing venture        Cost Number of   
                              capital portfolio at             investments 
                                              cost       £'000             
Consumer goods & services,                    29.9       2,691            5
leisure & publishing                                                       
Software                                      25.2       2,267            8
Industrial products &                         18.6       1,669            4
Internet                                       9.5         856            2
Electronics &                                  7.4         668            2
Healthcare                                     5.0         444            1
Semiconductors                                 4.4         396            1
                                             100.0       8,991           23

Valuation of the venture capital portfolio

The unquoted investments have been valued in line with the accounting policies
which are based on the BVCA Guidelines.

Setting reasonable valuations on venture capital investments presents difficult
issues of judgment. As noted above, provisions have been made in respect of a
number of investments to reflect the terms on which a recent private equity
transaction has been concluded or where the business concerned has fallen
behind plan.

Outlook for the venture capital portfolio

In addition to the active involvement of members of Quester's investment team
in the key strategic business planning decisions of individual investee
companies, the team as a whole regularly conducts reviews of the portfolio to
identify those companies most likely to provide attractive opportunities for
capital growth, to review their potential requirements for further rounds of
finance and to determine what actions members of the team can take in helping
their managements develop the full potential of their businesses. The Quester
team believes that, despite the difficulties suffered in the last two or three
years by a number of the companies in which Quester VCT has invested, the
portfolio at 31 January 2004 holds a number of attractive investments with good
potential for future capital growth.

It is emphasized, however, that a number of the companies concerned are still
at a relatively early stage of development. Some of those involved in
technology-related opportunities, for example, while showing satisfactory
underlying development in their businesses, may still have only limited sales
revenues and may still be loss-making.

Reserves for follow-on investment

Many of the companies in which Quester VCT has invested will require further
rounds of finance as they grow. It is important that Quester VCT should be in a
position to contribute to this funding process, provided the companies
concerned continue to make satisfactory progress. For this purpose the Company
holds reserves for further investment in these existing portfolio companies.
These reserves are represented in terms of assets by the portfolio of FTSE 350
equities and fixed-interest securities referred to below, and are considered
currently to be at a satisfactory level in relation to

the likely requirements.

FTSE 350 equity and fixed interest portfolio

The portfolio of FTSE 350 equities and fixed interest securities is retained as
a reserve for potential future venture capital investment. It is managed on
behalf of the Company by UBS Laing & Cruickshank Limited.

The FTSE 350 holdings, covering 22 investments, stood at a valuation of some £
2.0 million against an overall cost of £2.2 million as at the year end, while
the fixed interest holdings with an amortized cost of £3.0 million were around
break-even. This portfolio showed an unrealised gain over the year of £380,000,
reflecting share price movements among the FTSE 350 equity holdings.


While business conditions vary in the different sectors in which the Company
holds investments, the performance and prospects of a number of companies in
the portfolio give cause for optimism. The current level of activity in
relation to certain of the companies, and the opportunities now beginning to
open up, suggest favourable prospects for the future.

We continue to work very closely with many of our portfolio companies to
rebuild value and improve the prospects for growth. The Company retains a
satisfactory level of cash reserves to contribute to the further funding of
existing portfolio companies.

Quester Capital Management Limited

6 May 2004


Ten largest venture capital     Industry sector     Cost     Valuation     % of
investments by value                                                       fund
                                                       £'000     £'000         
                                                                       by value
HTC Healthcare Group            Consumer services      1,000     1,000     5.9%
Methuen Publishing Limited      Publishing               751       751     4.4%
Sift Group Limited              Internet                 875       729     4.3%
Sibelius Software Limited       Software                 700       700     4.1%
Advanced Valve Technologies     Industrial products    2,392       598     3.5%
Limited                         & services                                     
The Casella Group Limited       Industrial products    1,065       576     3.4%
                                & services                                     
Artisan Software Tools Limited  Software               1,377       450     2.6%
International diagnostics Group Healthcare               930       444     2.6%
Linguaphone Group plc           Consumer goods           840       420     2.5%
XKO Group plc                   Software                 505       400     2.3%
                                                      10,435     6,068    35.6%
Other venture capital                                  9,508     2,923    17.1%
Total venture capital investments                     19,943     8,991    52.7%
Listed fixed interest                                  3,040     3,020    17.7%
Listed FTSE 350 equity                                 2,170     2,038    12.0%
Total investments                                     25,153    14,049    82.4%
Cash and other net current assets                                3,009    17.6%
Net assets                                                      17,058   100.0%



                         Notes  2004      2003     
                                £'000     £'000    
Loss on realisation of          (1,169)   (2,373)  
Income                     1    456       412      
Investment management      2    (387)     (494)    
Other expenses             3    (287)     (263)    
Loss on ordinary                (1,387)   (2,718)  
activities before                                  
Tax on ordinary                 -         -        
Loss on ordinary                (1,387)   (2,718)  
activities after                                   
Dividends paid and              -         -        
Transfer from reserves          (1,387)   (2,718)  
Basic loss per share       5    (4.0)p    (7.8)p   
Diluted loss per share     5    (4.0)p    (7.8)p   

All items in the above statement derive from continuing operations.

The Company has only one class of business and derives its income from
investments made in shares and securities and from bank deposits.

In accordance with Financial Reporting Standard (FRS) 14, the outstanding
options give rise to no dilution to the return per share.



                                        Notes             2004           2003
                                                         £'000          £'000
Loss on ordinary activities after                      (1,387)        (2,718)
Unrealised loss on revaluation of                      (1,550)        (4,308)
Total gains and losses recognised                      (2,937)        (7,026)
during the period                                                            
Total recognised losses per share         5             (8.5)p        (20.1)p



                                                          2004           2003
                                                         £'000          £'000
Loss on ordinary activities before                     (1,387)        (2,718)
Realisation of prior years' unrealised                   (597)        (4,112)
losses on investments                                                        
Historical cost loss on ordinary                       (1,984)        (6,830)
activities before taxation                                                   
Historical cost loss for the year                      (1,984)        (6,830)
retained after taxation and dividends                                        


                                                            2004      2003     
                                                            £'000     £'000    
Fixed assets                                                                   
Investments                                                 14,049    18,866   
Current assets                                                                 
Debtors                                                     1,721     847      
Cash at bank                                                1,716     944      
                                                            3,437     1,791    
Creditors (amounts falling due within one year)             (428)     (362)    
Net current assets                                          3,009     1,429    
Net assets                                                  17,058    20,295   
Capital and reserves                                                           
Called-up equity share capital                              1,704     1,736    
Share premium account                                       2,787     2,787    
Special reserve                                             15,129    17,559   
Revaluation reserve                                         (5,644)   (4,691)  
Profit and loss account                                     3,082     2,904    
Total equity shareholders' funds                            17,058    20,295   
Net asset value per share                                   50.1p     58.4p    
Diluted net asset value per share                           50.1p     58.4p    

The financial statements were approved by the directors on 6 May 2004 and are
signed on their behalf by:

Tom Scruby




                                                            2004      2003     
                                                            £'000     £'000    
Net cash outflow from operating activities                  (936)     (670)    
Financial investment                                                           
Purchase of venture capital investments                     (1,935)   (2,223)  
Purchase of FTSE 350 equities and fixed interest            (3,993)   (3,490)  
Sale/redemption of venture capital investments              3,257     3,758    
Sale/redemption of FTSE 350 equity and fixed                4,679     2,462    
interest securities                                                            
Total financial investment                                  2,008     507      
Buy-in of shares                                            (300)     (286)    
Prior year costs associated with the buy-in of              -         (7)      
Total financing                                             (300)     (293)    
Increase / (decrease) in cash for the year                  772       (456)    
Reconciliation of net cash flow to movement in net                             
Increase / (decrease) in cash for the year                  772       (456)    
Net funds at the start of the year                          944       1,400    
Net funds at the end of the year                            1,716     944      


1 Income                                                  2004       2003      
                                                          £'000      £'000     
Dividend income                                                                
Unlisted companies                                        37         34        
Listed companies                                          89         77        
Interest receivable                                                            
Fixed interest securities                                 136        156       
Loans to unquoted companies                               112        96        
Bank deposits                                             31         48        
Other income                                              51         1         
                                                          456        412       

2 Investment Management Fee            2004       2003
                                      £'000      £'000
Investment management fee               387        494
Irrecoverable VAT                        50         27
                                        437        521

Quester Capital Management Limited ('QCML') provides investment management
services to the Company under an agreement dated 22 February 1996 as amended by
a supplemental agreement dated 16 January 1997, a second supplemental agreement
dated 30 June 1998 and a third supplemental agreement dated 8 September 1998.

QCML is a wholly owned subsidiary of Querist Limited, a company in which APG
Holmes and JA Spooner are beneficial shareholders. APG Holmes and JA Spooner
are executive directors of QCML.

QCML receives a management fee, payable quarterly in arrears, at the rate of
2.5% on the value of the audited net assets of the Company as at the end of the
previous accounting period. This charge is capped to ensure that the Company's
Running Costs do not exceed 3.25% of the closing net asset value. The
management fee for the year amounted to £387,000 (2003: £494,000) net of the
amount recoverable from QCML in respect of the cap.

QCML also provides administrative and secretarial services to the Company for
which it is entitled to a fee of £42,000 per annum (based on an amount which is
adjusted in line with the RPI), which is included in other expenses (note 3).

  * Other expenses                                     2004        2003       
                                                       £'000       £'000      
Administrative and secretarial services                42          40         
Directors' remuneration (note 4)                       39          39         
Auditor's remuneration - audit services                20          19         
- non audit services                                   9           7          
Legal and professional expenses                        19          20         
Irrecoverable VAT                                      76          67         
Other expenses                                         82          71         
                                                       287         263        

  * Directors' remuneration
                                                        2004       2003      
                                                        £'000      £'000     
Fees paid to directors                                  12         12        
Amounts paid to third parties, excluding VAT, in        27         27        
consideration of the services of directors                                   
                                                        39         39        

  * Loss per share
The loss per share of 4.0p (2003: loss per share of 7.8p) is based on the loss
on ordinary activities after tax of £1,387,000 (2003: loss of £2,718,000) and
on the weighted average number of ordinary shares in issue during the year of
34,471,086 (2003: 35,007,514).There is no dilution effect in respect of the
years ended 31 January 2004 and 31 January 2003.

The total recognised losses per share of 8.5p (2003: 20.1p) is based on the
total recognised loss for the year of £2,937,000 (2003: net loss of £7,026,000)
and on the weighted average number of ordinary shares in issue during the year
of 34,471,086 (2003: 35,007,514).

6 Net asset value per share

The calculation of net asset value per share as at 31 January 2004 is based on
net assets of £17,058,000 (2003: £20,295,000) divided by the 34,072,144
ordinary shares in issue at that date (2003: 34,725,817). There is no dilution
effect in respect of the years ended 31 January 2003 and 31 January 2004.

The financial information set out above does not constitute the Company's
statutory accounts for the year ended 31 January 2004. The statutory accounts
for the year ended 31 January 2004 will be finalised on the basis of the
financial information presented by the directors in the preliminary
announcement and will be delivered to the Registrar of Companies following the
Company's Annual General Meeting.

Copies of the full financial statements for the year ended 31 January 2004 are
expected to be posted to shareholders on 7 May 2004 and will be available to
the public at the registered office of the Company at 29 Queen Anne's Gate,
London, SW1H 9BU.

A copy of the above document has been submitted to the UK Listing Authority,
and will shortly be available for inspection at the UK Listing Authority's
Document Viewing Facility, which is situated at:

Financial Services Authority

25 The North Colonnade

Canary Wharf


E14 5HS



a d v e r t i s e m e n t